pageInfo({
    time : "1261216617482"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USLK33009820090120"
	        , headline : "UPDATE 3-Teva and Lonza link to tap biosimilar drugs market"
	        , keywords : "[Pharmaceuticals - generic and speciality, Pharmaceuticals (sub-industry), Emerging countries, United States of America, Biotechnology, Chemicals, Mergers and Acquisitions (including Changes of Ownership), Switzerland, Western Europe, Europe, Israel, Middle East, Healthcare, Pharmaceuticals and biotechnology, Central and Eastern Europe, Economic news, EC, business/financial pages]"
	        , tickers : "[xt;RO, us;AZN, us;AMGN, TEVA.O, mx;WYE, mx;LLY, mx;AMGN, MRK.N, LONN.VX, LLY.N, il;TEVA, gb;LEL, us;AZNC, us;AZND, xt;MRK, us;WYE, us;TEVJ, us;TEVA, us;RHHV, us;RHHQ, us;MRK, us;MERP, us;LLY, us;DNA, us;BIIB, gb;BNI, gb;AZNX, gb;AZND, de;IDP, de;AHPX, de;AHPS, de;AHPF, de;AHP, ch;RO, ch;MRK, ch;LON, ch;JKT, ch;AMGN, AZN.L, de;IDPF, de;IDPS, de;IDPX, gb;AZN, de;TEVF, de;TEV, de;RHOF, de;RHO, de;MRK, de;LO3X, de;LO3S, de;LO3F, de;LO3, AMGN.O, TEVA.TA]"
	    }
	    , channel : {
	        id : "1000"
	        , name : "companyNewsAndPR"
	        , title : "Company News and Press Releases"
	    }})